# XORTX Therapeutics Inc.: Form 6-K, filed Mar 20, 2024

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2024-03-20
- Accepted by EDGAR: Mar 19, 2024, 19:17 ET
- Period: 2024-03-19
- Accession: 0001171843-24-001463
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184324001463/f6k_031924.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184324001463/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184324001463/f6k_031924.htm

Filed Mar 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-001463. Last ingested by Listed: Nov 14, 2026, 22:48 ET. No prices; not investment advice.
